183 related articles for article (PubMed ID: 29207378)
1. Characteristics of Hepatocellular Carcinoma Aggressiveness Factors in Turkish Patients.
Akkiz H; Carr BI; Yalçın K K; Guerra V; Kuran S; Altıntaş E; Üsküdar O; Karaoğullarından Ü; Özakyol A; Tokmak S; Yücesoy M; Bahçeci Hİ; Ülkü A; Akçam T; Yalçın Polat K; Ekinci N; Şimşek H; Örmeci N; Sonsuz A; Demir M; Kılıç M; Uygun A; Ballı T; Demir A; Arslan B; Doran F
Oncology; 2018; 94(2):116-124. PubMed ID: 29207378
[TBL] [Abstract][Full Text] [Related]
2. Small hepatocellular carcinomas and thrombocytopenia.
Carr BI; Guerra V; De Giorgio M; Fagiuoli S; Pancoska P
Oncology; 2012; 83(6):331-8. PubMed ID: 23006906
[TBL] [Abstract][Full Text] [Related]
3. Macroscopic Portal Vein Thrombosis in HCC Patients.
Akkiz H; Carr BI; Kuran S; Karaoğullarından Ü; Üsküdar O; Tokmak S; Arslan B; Doran F; Balli HT; Ülkü A; Akçam TA; Bahçeci Hİ; Polat KY; Örmeci N; Şimşek H; Sonsuz A; Demir A; Altıntaş E; Demir M; Yalçın K; Ekinci N; Harmancı Özakyol A; Yücesoy M; Uygun A; Guerra V; Delik A; Tokat Y; Yilmaz S; Bektaş A; Kılıç M
Can J Gastroenterol Hepatol; 2018; 2018():3120185. PubMed ID: 30009156
[TBL] [Abstract][Full Text] [Related]
4. Association of abnormal plasma bilirubin with aggressive hepatocellular carcinoma phenotype.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Ludovico Rapaccini G; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Apr; 41(2):252-8. PubMed ID: 24787296
[TBL] [Abstract][Full Text] [Related]
5. Significance of platelet and AFP levels and liver function parameters for HCC size and survival.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Int J Biol Markers; 2014 Sep; 29(3):e215-23. PubMed ID: 24526315
[TBL] [Abstract][Full Text] [Related]
6. Trends in Tumor Indices in Relation to Increased Hepatocellular Carcinoma Size: Evidence for Tumor Evolution as a Function of Growth.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2020 Dec; 51(4):1215-1219. PubMed ID: 33006073
[TBL] [Abstract][Full Text] [Related]
7. Thrombocytopenia in relation to tumor size in patients with hepatocellular carcinoma.
Carr BI; Guerra V; Pancoska P
Oncology; 2012; 83(6):339-45. PubMed ID: 23006937
[TBL] [Abstract][Full Text] [Related]
8. Low alpha-fetoprotein HCC and the role of GGTP.
Carr BI; Guerra V; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Di Marco M; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F
Int J Biol Markers; 2014 Dec; 29(4):e395-402. PubMed ID: 24832180
[TBL] [Abstract][Full Text] [Related]
9. Serum albumin levels in relation to tumor parameters in hepatocellular carcinoma patients.
Carr BI; Guerra V
Int J Biol Markers; 2017 Oct; 32(4):e391-e396. PubMed ID: 28862714
[TBL] [Abstract][Full Text] [Related]
10. Platelet-related phenotypic patterns in hepatocellular carcinoma patients.
Carr BI; Lin CY; Lu SN
Semin Oncol; 2014 Jun; 41(3):415-21. PubMed ID: 25023358
[TBL] [Abstract][Full Text] [Related]
11. Low Alpha-Fetoprotein Levels Are Associated with Improved Survival in Hepatocellular Carcinoma Patients with Portal Vein Thrombosis.
Carr BI; Guerra V
Dig Dis Sci; 2016 Mar; 61(3):937-47. PubMed ID: 26576554
[TBL] [Abstract][Full Text] [Related]
12. Relationships Between Indices of Tumor Aggressiveness in Hepatocellular Carcinoma.
Carr BI; Guerra V; Donghia R; Yilmaz S
J Gastrointest Cancer; 2021 Dec; 52(4):1340-1349. PubMed ID: 34611834
[TBL] [Abstract][Full Text] [Related]
13. Identification of two clinical hepatocellular carcinoma patient phenotypes from results of standard screening parameters.
Carr BI; Pancoska P; Giannini EG; Farinati F; Ciccarese F; Rapaccini GL; Marco MD; Benvegnù L; Zoli M; Borzio F; Caturelli E; Chiaramonte M; Trevisani F;
Semin Oncol; 2014 Jun; 41(3):406-414. PubMed ID: 25023357
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma size: platelets, γ-glutamyl transpeptidase, and alkaline phosphatase.
Carr BI; Guerra V
Oncology; 2013; 85(3):153-9. PubMed ID: 23988857
[TBL] [Abstract][Full Text] [Related]
15. Hepatocellular Carcinoma Extrahepatic Metastasis in Relation to Tumor Size and Alkaline Phosphatase Levels.
Carr BI; Guerra V
Oncology; 2016; 90(3):136-42. PubMed ID: 26866819
[TBL] [Abstract][Full Text] [Related]
16. Acute Portal Vein Thrombosis Predicts Concomitant Diagnosis of Hepatocellular Carcinoma in Cirrhotic Patients.
Khoury T; Massarwa M; Hazou W; Daher S; Hakimian D; Benson AA; Ashqar T; Mahamid M; Yaari S
J Gastrointest Cancer; 2019 Dec; 50(4):759-762. PubMed ID: 30043228
[TBL] [Abstract][Full Text] [Related]
17. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.
Rabie H; Othman W; Elsabaawy DM; Elshemy EE; Abdelmageed N; Khalaf FA; Bedair HM
Asian Pac J Cancer Prev; 2021 Jan; 22(1):267-275. PubMed ID: 33507708
[TBL] [Abstract][Full Text] [Related]
18. Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.
Giannini EG; Sammito G; Farinati F; Ciccarese F; Pecorelli A; Rapaccini GL; Di Marco M; Caturelli E; Zoli M; Borzio F; Cabibbo G; Felder M; Gasbarrini A; Sacco R; Foschi FG; Missale G; Morisco F; Svegliati Baroni G; Virdone R; Trevisani F;
Cancer; 2014 Jul; 120(14):2150-7. PubMed ID: 24723129
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Radioembolization in the Treatment of Hepatocellular Carcinoma with Portal Vein Invasion: Resin versus Glass Microspheres.
Biederman DM; Titano JJ; Tabori NE; Pierobon ES; Alshebeeb K; Schwartz M; Facciuto ME; Gunasekaran G; Florman S; Fischman AM; Patel RS; Nowakowski FS; Kim E
J Vasc Interv Radiol; 2016 Jun; 27(6):812-821.e2. PubMed ID: 27062356
[TBL] [Abstract][Full Text] [Related]
20. Corelation of serum alpha fetoprotein and tumor size in hepatocellular carcinoma.
Abbasi A; Bhutto AR; Butt N; Munir SM
J Pak Med Assoc; 2012 Jan; 62(1):33-6. PubMed ID: 22352098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]